Justification_E_2-61 NO. AC. 003/2018 14 August 2018 Subject: Clarification of changes in operating performance of more than 20% To: The President of the Stock Exchange of Thailand M. K. Real Estate
Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the three-month period at the end of 30th September 2018 as
, 2019 Subject Explanation and analysis of Management for second quarter 2019 Attention Directors and manager The Stock Exchange of Thailand Inter pharma Public Company Limited (“the Company”) would like
วันที่ 14 สิงหาคม 2550 DEMCO Public Company Limited No. Demco AC004/2019 November 13, 2019 Subject : The company’s operating result for the 3rd quarter of year 2019 To : The president, The Stock
Management discussion of three-month operating result ending March 31, 2020 To The President of the Stock Exchange of Thailand Matching Maximize Solution Public Company Limited (the Company) would like to
Ref : JSP 035/2563 August 10, 2020 Subject : Report the operating results for the 2nd quarter ended June 30, 2020 To : The President The Stock Exchange of Thailand Dear Sir, Re. Operating report for
CWTACC2020/006 August 14, 2020 Subject: Managing Discussion and Analysis for Q2/2020 To: Managing Director The Stock Exchange of Thailand The company would like to report to operating results of the
. 004 / 2021 March 1, 2021 Subject Explanation of the operating performance for the year 2020 To Managing Director The Stock Exchange of Thailand Pan Asia Footwear Public Company Limited would like to
www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the
results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech